瘤管理方面的进步:利用基因组的潜力
Yash Verma1, Arosh S Perera Molligoda Arachchige1
1From the Norfolk and Norwich University Hospital, Colney Ln, Norwich NR4 7UY, England (Y.V.); and Faculty of Medicine, Humanitas University, Via Rita Levi Montalcini, 4, 20072 Milan, Italy (A.S.P.M.A.).
Radiology. Imaging cancer
|April 19, 2024
概括
组织缩使用聚焦超声波来非侵入性地切除组织,为各种瘤提供了对手术的有希望的替代方案. 临床试验显示了良好的安全性和有效性,目前正在进行研究以优化这种非热性组织切除技术.
科学领域:
- 在瘤学瘤学.
- 医学物理 医学物理
- 手术创新 在外科创新.
背景情况:
- 传统的组织切除方法通常具有侵入性,并具有显著的副作用.
- 组织缩提供了一个使用聚焦超声波的非侵入性,非热疗法替代方案.
- 组织的机械分成由化气泡是核心机制.
研究的目的:
- 审查基因组作为一种非侵入性切除技术的意义.
- 总结关于组织的疗效和安全性的临床前和临床研究结果.
- 为了探索潜在的未来的临床应用 histotripsy.
主要方法:
- 输送高强度聚焦超声波 (HIFU) 到目标组织.
- 诱导化气泡用于机械组织分化.
- 审查现有的临床前和临床文献关于组织缩.
主要成果:
- 在肝脏,胰腺,脏和前列腺瘤的临床前和临床研究中,体缩显示出有效性.
- 安全结果总体上是有利的,报告的不良影响最小.
- 该技术机械地将组织碎片化为非细胞碎片,以便免疫系统吸收.
结论:
- 组织缩是一种可行的非侵入性组织切除技术,有可能取代手术干预.
- 进一步的研究是必要的,以优化组织缩并了解其长期影响.
- 该技术在各种瘤疾病中显示出有前途,特别是在腹部和生殖尿道应用中.
相关概念视频
Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...


